Evidence map›Paper›PMID 33500569›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

Increasing access to individualized medicine: a matched-cohort study examining Latino participant experiences of genomic screening.

Joel E Pacyna, Gabriel Q Shaibi, Alex Lee, Jamie O Byrne, Idali Cuellar, Erica J Sutton, Valentina Hernandez, Noralane M Lindor, Davinder Singh, Iftikhar J Kullo and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Joel E PacynaBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.
Gabriel Q ShaibiCenter for Health Promotion and Disease Prevention, Arizona State University, Phoenix, AZ, USA.
Alex LeeDivision of Biostatistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Jamie O ByrneDivision of Biostatistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Idali CuellarCenter for Individualized Medicine, Mayo Clinic, Phoenix, AZ, USA.
Erica J SuttonBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.
Valentina HernandezMountain Park Health Center, Phoenix, AZ, USA.
Noralane M LindorCenter for Individualized Medicine, Mayo Clinic, Phoenix, AZ, USA.
Davinder SinghMountain Park Health Center, Phoenix, AZ, USA.
Iftikhar J KulloDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Richard R SharpBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA. sharp.richard@mayo.edu.ORCID http://orcid.org/0000-0001-5441-2084
Mayo Clinic · USMayo Clinic in Florida · USMountain Park Health Center · USArizona State University · USMayo Clinic in Arizona · US

Funding

Genomic Basis of Susceptibility to COVID-19 Infection and its ComplicationsU01HG006379 · NHGRI · MAYO CLINIC ROCHESTER · PI Richard R. Sharp · 2011 to 2026
$16.5M
NHGRI NIH HHS U01 HG006379
6 · The paper itself

Abstract

purposeMultiple efforts are underway to increase the inclusion of racial minority participants in genomic research and new forms of individualized medicine. These efforts should include studies that characterize how individuals from minority communities experience genomic medicine in diverse health-care settings and how they integrate genetic knowledge into their understandings of health-care needs.

methodsAs part of a large, multisite genomic sequencing study, we surveyed individuals to assess their decision to pursue genomic risk evaluation. Participants included Latino patients recruited at Mountain Park Health Center, a Federally Qualified Health Center in Phoenix, Arizona, and non-Latino patients recruited at a large academic medical center (Mayo Clinic in Rochester, MN). Both groups agreed to receive individualized genomic risk assessments.

resultsComparisons between cohorts showed that Latino respondents had lower levels of decisional conflict about pursuing genomic screening but generally scored lower on genetic knowledge. Latino respondents were also more likely to have concerns about the misuse of genomic information, despite both groups having similar views about the value of genomic risk evaluation.

conclusionOur results highlight the importance of evaluating sociocultural factors that influence minority patient engagement with genomic medicine in diverse health-care settings.

Indexed as

Hispanic or LatinoPrecision MedicineCohort StudiesGenomicsHumansMinority Groups

Identifiers

PMID33500569
PMCPMC8495890
OpenAlexW3124435955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.